Results
10
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
10 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
PHO | NOK 52.80 | -2.0% | 0.6% | NOK 1.4b | NOK 84.50 | PE111.4x | E86.0% | 0% | ||
VISTN | NOK 24.20 | -4.7% | 9.0% | NOK 1.1b | n/a | PE17.5x | n/a | 4.1% | ||
AZT | NOK 13.86 | 0.7% | -62.7% | NOK 707.8m | NOK 16.00 | PE152.9x | E73.8% | n/a | ||
NAVA | NOK 23.50 | -1.7% | -36.3% | NOK 415.1m | NOK 40.50 | PE21.2x | E29.2% | n/a | ||
TRMED | NOK 1.66 | 19.0% | 19.1% | NOK 388.9m | n/a | PB1.5x | n/a | n/a | ||
BGBIO | NOK 6.14 | -12.3% | -61.0% | NOK 239.9m | NOK 20.00 | PS460.5x | E-21.7% | n/a | ||
ABS | NOK 2.42 | 21.0% | -73.6% | NOK 61.4m | n/a | PS1.9x | E-12.8% | n/a | ||
ULTI | NOK 1.74 | -5.8% | -98.4% | NOK 59.9m | NOK 5.75 | PB0.3x | E25.5% | n/a | ||
PCIB New | NOK 1.23 | -18.7% | -49.1% | NOK 45.9m | n/a | PS7.7x | n/a | n/a | ||
SOFTX | NOK 0.013 | -1.5% | -99.7% | NOK 25.0m | n/a | PS15x | n/a | n/a |